Navigation Links
Study: Medicare Competitive Bidding Program Could Impede Seniors' Access to Diabetes Testing Supplies
Date:6/18/2008

Coalition Aims to Support and Educate Seniors

WASHINGTON, June 18 /PRNewswire-USNewswire/ -- The new Medicare Durable Medical Equipment competitive bidding program that starts July 1 could make it more difficult for seniors to manage their diabetes care, according to a new analysis released today from The George Washington University School of Public Health and Health Services.

"This analysis shows how the competitive bidding program makes an already vulnerable population even more vulnerable. Medicare must immediately take steps to help seniors with diabetes avoid confusion and ensure that their treatments are not interrupted," said Sara Rosenbaum, the lead author of the study and chair of George Washington University's Department of Health Policy.

The analysis, sponsored by the Diabetes Access to Care Coalition (DACC), examined how Medicare's competitive bidding program for Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) could impact how seniors manage their diabetes.

The program is scheduled to begin July 1 in 10 metro areas: Charlotte, N.C.; Cincinnati, Cleveland; Dallas-Fort Worth, Tex.; Kansas City, Mo.; Miami, Riverside, Calif.; Orlando, Fla.; Pittsburgh, Pa. and San Juan, Puerto Rico. The competitive bidding program limits the number of mail order suppliers that Medicare beneficiaries in the metro areas can use to obtain their diabetes testing supplies.

"This new Medicare program needs more protections for beneficiaries to ensure that they won't lose access to their diabetes management supplies. As diabetes educators, we know that access to supplies is critical for effective management of this disease. Any disruption in care for seniors with diabetes is simply unacceptable," said Donna Rice, RN, CDE and Past-President of the American Association of Diabetes Educators.

The Coalition is concerned that competitive bidding for diabetic testing supplies may cause seniors to lose access to th
'/>"/>

SOURCE Diabetes Access to Care Coalition
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. U of M study: Early treatment can reverse heart damage
2. New study: Pine bark reduces perimenopausal symptoms
3. U of M study: Health food supplement may curb addiction of pathological gamblers
4. New study: Pine bark extract reduces ADHD symptoms in children
5. Kaiser Permanente study: Alcohol amount, not type -- wine, beer, liquor -- triggers breast cancer
6. UGA study: Youth exposed to smokeless tobacco ads despite settlement
7. New National Medicaid Study: Minnesota Under Funds Seniors Nursing Home Care $167 Million Annually
8. Study: Modafinil is effective in treating excessive sleepiness
9. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
10. New study: pine bark extract boosts nitric oxide production
11. Study: HPV test beats Pap in detecting cervical cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 22, 2013 Feed additives have ... production industry value chain. Most of the feed additives ... injectable, pellets, liquids, and powders. There are variety of ... and concentrations depending upon the type of animal and ... vitamins that provide essential nutrition to the animal in ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Medical Ministry ... the prestigious 2013 Top-Rated Award by GreatNonprofits , the ... are excited to be named a Top-Rated 2013 Nonprofit,” says ... the dedication of our over 3000 Volunteers and Staff serving ... significant as it came from those that have seen our ...
(Date:5/21/2013)... on a large scale is the cornerstone of ... better outcomes, better value and better experience of ... patient-centered medical home model offers a viable solution ... of Health and Human Services, Agency for Healthcare ... more about the processes and determinants of successful ...
(Date:5/21/2013)... 21, 2013 Mecklenburg EMS Agency (Medic) ... hold a free Community Wellness Fair to educate the public ... will be held on Wednesday, May 22, 2013 from 4:00 ... (8100 Old Mallard Creek Road, Charlotte, NC 29262). ... and the Mecklenburg County Department of Social Services ...
(Date:5/21/2013)... May 2013, Paris, France: The Orsiro stent, which ... a biodegradable polymer, demonstrated non-inferiority to the Xience ... of in-stent late lumen loss at nine months ... at EuroPCR 2013 today. , The BIOFLOW-II substudy ... (OCT) to quantitatively assess neointimal hyperplasia and stent ...
Breaking Medicine News(10 mins):Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2
... 12 The Female Health Company (NYSE Alternext: ... (FDA) Obstetrics and Gynecology Devices Advisory Committee has unanimously voted ... is approvable with a single condition. , ... the product is approvable with the condition that the FC2 ...
... HOUSTON, Dec. 12 Access MediQuip, LLC, ... medical implantable device management,solutions to the healthcare ... industry,s first national contract for device benefit ... with WellPoint, Inc. to deliver,implantable device management ...
... and only approved peginterferon in combination with ribavirin for ... medical need , , ... SGP ) today announced that the U.S. Food ... PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy ...
... director for the Pew Campaign on Human Health and ... U.S. Food and Drug Administration,s decision to reverse its ... animal agriculture: , , ... the increase in antibiotic-resistant infections - a fact long ...
... Hospitals Case Medical Center in conjunction with Sodexo Health Care ... Nosh 24/6 unit, the original certified kosher hot food vending ... machine in the state of Ohio, offering patients and their ... , , University Hospitals prides ...
... Life Insurance,Company (John Hancock) is reinforcing its commitment ... training requirements through an,affiliation with the ClearCert Clearinghouse. ... in the year and effective January 1, 2009,will ... , Since ...
Cached Medicine News:Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 2Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 3Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 4Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 5Health News:Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7Health News:Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming 2Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 2Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 3Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 2Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 3
(Date:5/21/2013)... 21, 2013  Lakeland Industries, Inc. (NASDAQ: ... industrial protective clothing for industry, municipalities, healthcare and ... levels, today announced that the Company accepted a ... Credit Facility subject to certain terms and conditions ... However, no assurances can be given that this ...
(Date:5/21/2013)... May 21, 2013   Regulus Therapeutics Inc . ... discovery and development of innovative medicines targeting microRNAs, today ... Ph.D., Chief Operating Officer and Executive Vice President, Finance, ... 38th Annual Healthcare Conference on Wednesday, May 29, 2013 ... at the Westin Boston Waterfront Hotel. The ...
(Date:5/21/2013)... , May 21, 2013  Tom Daulton, CEO of Mammotome, ... of the Year by the Cincinnati ... was nominated by another local top executive who is also ... brand from Ethicon Endo-Surgery in March of 2010. Daulton will ... Awards program, presented by Huntington Bank, on May 22. ...
Breaking Medicine Technology:Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 3Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 4Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 5Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 6Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 7Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 8Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 9Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 10Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 11Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 12Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 13Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3
... - VASTox plc (AIM: VOX), a leading,UK biotechnology ... of £400,000 by the Welsh Development Agency,(”WDA”) under ... 12 months, will support the research and development,work ... the unique skills and expertise of its scientists,based ...
... 2007 /PRNewswire-USNewswire/ -- The,following statement may be attributed ... Medical Research (CAMR): , "In the face of ... the stroke of his veto pen deliberately to ... well as endanger,the future health and well being ...
Cached Medicine Technology:Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 2Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 3President Bush Ignores America's Plea for Support of Stem Cell,Research 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: